AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
Gene-Modified Cell-Based Therapy for AD prior to transplantation can be beneficial for increasing cell survival and making them more effective, and adapted cells could be used for the transfer of factors that can ameliorate neurological complaints.
BACKGROUND Alzheimer's disease (AD) is a common neurodegenerative disorder characterized by progressive impairments in learning and memory. Substantial evidence indicates that dysfunction of the ubiquitin-proteasome system (UPS) in the AD brain leads to aberrant protein aggregation, ultimately resulting in synaptic dys...
Investigation of the neuroprotective potential and associated signaling alterations of erinacine C using APP/PS1 transgenic mice and Aβ25-35-induced PC12 cells suggest that EC may mitigate cognitive impairment and neurodegeneration in parallel with alterations in the Akt/GSK3β/tau/caspase-3 signaling response.
The biogenesis, classification, isolation methods, and molecular content of EVs are reviewed, and their role in the pathogenesis, diagnosis, and treatment of the most important neurodegenerative diseases is analyzed.
The phenotypic and functional alterations of B cells in AD are reviewed, integrating evidence from experimental models and human studies to evaluate whether B cells constitute an underappreciated component of the adaptive immune response in AD and whether they represent a compelling immunotherapeutic target.
AppSAA mice recapitulate age-dependent, human-relevant AD phenotypes with defined therapeutic windows for preclinical research and is available without restriction from The Jackson Laboratory.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.